Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) Shares Outstanding (Diluted Average): 2021-2024

Historic Shares Outstanding (Diluted Average) for Biodesix (BDSX) over the last 4 years, with Dec 2024 value amounting to $129.7 million.

  • Biodesix's Shares Outstanding (Diluted Average) rose 2.53% to $7.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.5 million, marking a year-over-year increase of 2.53%. This contributed to the annual value of $129.7 million for FY2024, which is 57.92% up from last year.
  • As of FY2024, Biodesix's Shares Outstanding (Diluted Average) stood at $129.7 million, which was up 57.92% from $82.1 million recorded in FY2023.
  • In the past 5 years, Biodesix's Shares Outstanding (Diluted Average) registered a high of $129.7 million during FY2024, and its lowest value of $27.4 million during FY2021.
  • Over the past 3 years, Biodesix's median Shares Outstanding (Diluted Average) value was $82.1 million (recorded in 2023), while the average stood at $84.6 million.
  • Data for Biodesix's Shares Outstanding (Diluted Average) shows a peak YoY spiked of 95.03% (in 2023) over the last 5 years.
  • Over the past 4 years, Biodesix's Shares Outstanding (Diluted Average) (Yearly) stood at $27.4 million in 2021, then soared by 53.86% to $42.1 million in 2022, then surged by 95.03% to $82.1 million in 2023, then soared by 57.92% to $129.7 million in 2024.